Toggle navigation
Home
Search
Services
Blog
Contact
About
Targeted Antigen Presentation
Segal, D.
Division of Cancer Biology and Diagnosis, United States
Search 940 grants from D. Segal
Search grants from Division of Cancer Biology and Diagnosis
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Senescence of Pre-Osteoclasts in Non-Traumatic OA
EEG Biomarkers of Psychosis Risk and Adolescent Neurodevelopment
The Maryland Prisoner Reentry Relocation Experiment
AP-1 Factors in the Pathogenesis and Progression of Benign Prostatic Hyperplasia
Role of Ectodermal Signals in Limb Bud Outgrowth and Development
Recently added grants:
Dissecting the role of PTEN in human disease by testing the effects of thousands of variants on multiple cellular phenotypes
Defining mechanisms of resistance to hormonal therapy in breast cancer
Competition, Bundled Care Payment, and Low-Value Cancer Care
Developing novel combination therapies for pancreatic cancer
SUMO1 inhibition compound as a new anticancer drug for glioblastoma therapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CB009290-01
Application #
3808611
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Division of Cancer Biology and Diagnosis
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Related projects
NIH 1992
Z01 CA
Targeted Antigen Presentation
Segal, D. / Division of Cancer Biology and Diagnosis
NIH 1991
Z01 CA
Targeted Antigen Presentation
Segal, D. / Division of Cancer Biology and Diagnosis
Comments
Be the first to comment on this grant